Sort
261,768 grants matching “gene therapy”
Molecular Profiling of Clinical Specimens
$3,225,664Daniel Edelman · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA
Novel Treatment Targets For Affective Disorders Through Cross-Species Investigation of Approach/Avoidance Decision Making
$3,225,604Diego A. Pizzagalli · Mclean Hospital · P50 · FY2020 · MH
Studies of inherited neuromuscular diseases
$3,225,145Christopher Grunseich · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS
Pharmacogenetics of Phase II Drug Metabolizing Enzymes
$3,225,056Richard M Weinshilboum · Mayo Clinic Rochester · U19 · FY2011 · GM
Nrf2 Activation for Addiction-Free Treatment of Neuropathic Pain
$3,224,916Peter M Grace · University Of Tx Md Anderson Can Ctr · RF1 · FY2019 · NS
Role of the Retrosplenial Cortex in the Progression of AD Pathogenesis in Mouse and Human
$3,221,450Kevin T Beier · University Of California-Irvine · RF1 · FY2025 · AG
Neural-immune Mechanisms and Synaptic Connectivity in Psychiatric Illness
$3,221,411Beth Ann Stevens · Boston Children'S Hospital · P50 · FY2025 · MH
Women's Interagency HIV Study (WIHS-V)
$3,221,271Kathryn M Anastos · Albert Einstein College Of Medicine, Inc · U01 · FY2017 · AI
MPD Research Consortium
$3,221,226Ronald Hoffman · Icahn School Of Medicine At Mount Sinai · P01 · FY2014 · CA
THERAPEUTIC INDEX OF ACUTE LYMPHOBLASTIC LEUKEMIA
$3,219,060Dana-Farber Cancer Institute · P01 · FY2003 · CA
Mayo Alzheimer's Disease Research Center
$3,218,144Ronald C Petersen · Mayo Clinic Rochester · P30 · FY2023 · AG
Institute for Clinical and Translational Research (KL2)
$3,217,916Daniel Ernest Ford · Johns Hopkins University · KL2 · FY2010 · RR
Therapeutic Index of Acute Lymphoblastic Leukemia
$3,217,162Stephen E Sallan · Dana-Farber Cancer Inst · P01 · FY2006 · CA
SAN ANTONIO CANCER INSTITUTE
$3,213,782Cancer Therapy And Research Center · P30 · FY2002 · CA
Characterization of Antigen-Specific Immune Response in ALS
$3,213,011Wassim Elyaman · Columbia University Health Sciences · RF1 · FY2025 · NS
Genetic and clinical studies of Gaucher disease and other lysosomal disorders
$3,211,711Ellen Sidransky · National Human Genome Research Institute · ZIA · FY2022 · HG
Therapeutic Index of Acute Lymphoblastic Leukemia
$3,211,219Stephen E Sallan · Dana-Farber Cancer Inst · P01 · FY2007 · CA
CHRONIC LYMPHOCYTIC LEUKEMIA RESEARCH CONSORTIUM
$3,210,960University Of California San Diego · P01 · FY2000 · CA
UCLA-CDU CFAR
$3,209,540Jerome A. Zack · University Of California Los Angeles · P30 · FY2023 · AI
Gene Therapy Platform for Rare Diseases
$3,208,999Na Yang · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR
The Risks and Opportunities of Homeostatic Repopulation
$3,208,387Stuart Johnston Knechtle · Duke University · U19 · FY2025 · AI
The Risks and Opportunities of Homeostatic Repopulation
$3,208,377Stuart Johnston Knechtle · Duke University · U19 · FY2024 · AI
Mechanisms regulating neurodegeneration and repair
$3,207,428Claire Le Pichon · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2023 · HD
Control Mechanisms for Matching ATP Supply and Demand in Heart Mitochondria
$3,205,998Steven Sollott · National Institute On Aging · ZIA · FY2021 · AG
Control Mechanisms for Matching ATP Supply and Demand in Heart Mitochondria
$3,203,961Steven Sollott · National Institute On Aging · ZIA · FY2020 · AG